RESEARCH TRIANGLE PARK, N.C., July 13 /PRNewswire/ -- Max Neeman International, India's
The medical writing team at Max Neeman has generated clinical study reports, protocols across various therapeutic areas including oncology, cardiology, endocrinology, and vascular diseases as well as investigator brochures and manuscripts.
India has become a major destination for medical writing services because of the stream of medical scientists entering the job market each year, including on average 3 million graduates and 700,000 post graduates. áThe focus on medical education propels India's cost advantage and competitiveness in the medical writing space.
The medical writing market has doubled in size during the past five years, increasing from an estimated US$ 345 million in 2003 to US$ 694 million in 2008 and is expected to grow further at an accelerated pace. áMax Neeman can provide cost savings of 35-50% for conduct of clinical trials and services in India compared to the United States.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 6 regional offices. áContact Donald Swankie, Vice President of Business Development via email to [email protected] or call +1.919.424.3345. áFor more information please visit www.neeman-medical.com.
SOURCE Max Neeman International
Subscribe to our Free Newsletters!